OS Therapies’ Paul Romness On The Future Of ADCs
14:42
How OS Therapies Succeeds By Putting Patients First
14:31
What’s Next For Adaptimmune?
55:26
Biotech Story Time With Tal Zaks, M.D. (Part 1)
31:15
Inside a Dopamine-Restoring Cell Therapy for PD with BlueRock Therapeutics' Dr. Amit Rakhit
25:36
Gates MRI’s Claire Wagner On The Fight Against TB
31:15
Seeking effective, safe treatment for all with precision dosing
51:49
Optimizing Lentiviral Purification: Enhancing Chromatography With Monoliths
17:26